HK Stock Market Move | ALPHAMAB-B(09966) rose by more than 3%, planning to conduct on-market repurchase of shares with a maximum amount of 20 million Hong Kong dollars.

ALPHAMAB-B (09966) rose by more than 3%, as of the time of writing, it has risen by 3.06% to HKD 13.46, with a turnover of HKD 31.4396 million. In terms of news, ConnoGen Pharma announced that, based on the general authorization granted to the board of directors (share repurchase authorization approved by shareholders at the annual general meeting held on June 12, 2025), the board of directors resolved on October 12, 2025, to repurchase ordinary shares (shares) of the company from time to time on the open market, with a maximum amount of HKD 20 million. The announcement stated that the board of directors believes that the current market price of the shares does not accurately reflect the company's intrinsic value, and also believes that this share repurchase will demonstrate the company's confidence in its own business outlook and prospects, ultimately benefiting the company and creating value for its shareholders. The board of directors believes that the company's current financial resources are sufficient to support the proposed share repurchase and maintain a healthy financial position.